XOMA Corporation
NASDAQ:XOMAP · NASDAQ Global Market
+$0.02 today
Vol 0.00M · Avg 0.00M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+7.68%
Period High
$27.25
Period Low
$23.63
Latest
$25.44
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Tectonic Therapeutic, Inc.
NASDAQ:TECX
$562.30M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$350.28M
Amarin Corporation plc
NASDAQ:AMRN
$330.93M
Silence Therapeutics plc
NASDAQ:SLN
$327.57M
Cellectis S.A.
NASDAQ:CLLS
$307.28M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$305.94M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$294.56M
AC Immune S.A.
NASDAQ:ACIU
$241.71M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$117.32M
Genelux Corporation
NASDAQ:GNLX
$110.03M
What is the latest XOMAP filing?
The latest filing shown is DEFA14A dated Jun 12, 2026.
How many recent filings does XOMAP have?
Intrinsic Alpha currently shows 20 recent filings for XOMAP.
Explore More
Continue the stock analysis
Jump to another research area for this company.